Zhuhai Sailong Pharmaceutical Co Ltd (002898) — Capital Reinvestment Ratio
Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a Capital Reinvestment Ratio of 0.87x as of June 2025, meaning it reinvests 1% of its operating cash flow (CN¥4.75 Million) in capital expenditures (CN¥4.15 Million). See 002898 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhuhai Sailong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Zhuhai Sailong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check 002898 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see Zhuhai Sailong Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.23x | CN¥19.06 Million | CN¥23.35 Million | ▲ +43.1% |
| 2023 | 0.86x | CN¥35.71 Million | CN¥30.58 Million | ▼ -49.5% |
| 2022 | 1.70x | CN¥14.12 Million | CN¥23.94 Million | ▲ +91.0% |
| 2021 | 0.89x | CN¥35.46 Million | CN¥31.47 Million | ▼ -99.8% |
| 2020 | 366.69x | CN¥174.69K | CN¥64.06 Million | ▲ +805.2% |
| 2018 | 40.51x | CN¥3.33 Million | CN¥134.84 Million | ▲ +3554.0% |
| 2017 | 1.11x | CN¥85.13 Million | CN¥94.38 Million | ▲ +69.5% |
| 2016 | 0.65x | CN¥78.65 Million | CN¥51.43 Million | ▼ -34.3% |
| 2015 | 1.00x | CN¥47.44 Million | CN¥47.24 Million | ▲ +43.1% |
| 2014 | 0.70x | CN¥51.36 Million | CN¥35.74 Million | ▲ +712.9% |
| 2013 | 0.09x | CN¥64.84 Million | CN¥5.55 Million | — |